<p>药明康德 (NASDAQ:PAYX - 获取免费报告) 在周四向投资者发布的研究报告中，花旗集团的股票分析师将其目标价格从 145.00 美元上调至 158.00 美元，Benzinga 报道。该公司目前对这家商业服务提供商的股票给予 “中性” 评级。花旗集团的目标价格暗示该股票相较于之前的收盘价有 4.73% 的潜在上涨空间。</p>
<ul>
<li>为什么药明康德股票的下跌是当前周期中最佳机会</li>
</ul>
<p>其他一些股票分析师最近也对 PAYX 发表了评论。巴克莱将药明康德的目标价格从 135.00 美元上调至 140.00 美元，并在 12 月 23 日的研究报告中给予该股票 “等权重” 评级。瑞银集团将药明康德的目标价格从 152.00 美元上调至 155.00 美元，并在 3 月 4 日的报告中给予该股票 “中性” 评级。斯蒂费尔·尼古拉斯将药明康德的目标价格从 141.00 美元上调至 156.00 美元，并在周四的报告中给予该公司 “持有” 评级。最后，加拿大皇家银行在 12 月 20 日的研究报告中重新发布了 “行业表现” 评级，并设定了 148.00 美元的目标价格。两位分析师对该股票给予了卖出评级，十位分析师则给予了持有评级。根据 MarketBeat 的数据，药明康德的平均评级为 “持有”，共识目标价格为 136.83 美元。</p>
<p><strong>阅读我们对药明康德的最新分析</strong></p>
<h2>药明康德股票表现</h2>
<ul>
<li>在药明康德公司买入下跌的股票，以便在退休时获得薪水</li>
</ul>
<p>周四中午交易时，药明康德的股票上涨 0.68 美元，达到 150.87 美元。该公司的股票交易量为 1,049,015 股，而其平均交易量为 1,796,058 股。该公司的流动比率为 1.39，速动比率为 1.39，债务与股本比率为 0.20。药明康德的 52 周低点为 114.72 美元，52 周高点为 158.37 美元。该公司的 50 日移动平均线为 148.03 美元，200 日移动平均线为 143.04 美元。该公司的市值为 543.2 亿美元，市盈率为 31.77，市盈率/增长比率为 4.10，贝塔值为 0.98。</p>
<p>药明康德 (NASDAQ:PAYX - 获取免费报告) 最近在 3 月 26 日发布了季度财报。该商业服务提供商报告本季度每股收益为 1.49 美元，超出分析师一致预期的 1.48 美元 0.01 美元。该公司本季度的收入为 15.1 亿美元，而分析师预期的收入为 15.1 亿美元。药明康德的股本回报率为 45.28%，净利润率为 32.02%。该公司的季度收入同比增长 4.8%。去年同期，该公司每股收益为 1.38 美元。分析师平均预计药明康德在当前年度的每股收益为 4.99 美元。</p>
<h2>机构资金流入和流出</h2>
<ul>
<li>三家薪资公司遭遇重创，但一家看起来便宜</li>
</ul>
<p>几家机构投资者最近调整了对 PAYX 的持股。Meeder 资产管理公司在第四季度将其在药明康德的股份增加了 220.7%。Meeder 资产管理公司现在拥有 186 股该商业服务提供商的股票，价值 26,000 美元，此前在上个季度增持了 128 股。联合银行私人银行 UBP SA 在第四季度购买了药明康德的新头寸，价值约 28,000 美元。WealthTrak 资本管理公司在第四季度获得了药明康德的新股份，价值约 28,000 美元。Millstone Evans 集团在第四季度购买了药明康德的新股份，价值约 33,000 美元。最后，Avion Wealth 在第四季度将其在药明康德的持股增加了 469.8%。Avion Wealth 现在拥有 245 股该商业服务提供商的股票，价值 34,000 美元，此前在上个季度增持了 202 股。目前 83.47% 的股票由机构投资者和对冲基金持有。</p>
<h2>关于药明康德</h2>
<p>(获取免费报告)</p>
<p>药明康德公司及其子公司为美国、欧洲和印度的小型和中型企业提供集成人力资本管理解决方案（HCM），包括薪资、福利、人力资源（HR）和保险服务。它提供薪资处理服务；薪资税务管理服务；员工支付服务；以及合规服务，如新员工报告和扣押处理。</p>
<h2>阅读更多</h2>
<ul>
<li>五只我们更看好的股票，胜过药明康德</li>
<li>什么是空头头寸？如何使用它</li>
<li>便士股票激增 70%：买入的一个理由，卖出的五个理由</li>
<li>专家股票交易心理技巧</li>
<li>三大饮料股票带来丰厚利润</li>
<li>如何为初学者阅读股票图表</li>
<li>CarMax 和 Carvana：引领二手车市场</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEFZWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEFZWA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在药明康德吗？</h2>
<p>在你考虑药明康德之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而药明康德并不在名单上。</p>
<p>虽然药明康德目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

沛齐

<p>花旗集团已将 Paychex（NASDAQ:PAYX）的目标股价从 145.00 美元上调至 158.00 美元，维持 “中性” 评级。这表明该股相较于前一交易日收盘价有 4.73% 的潜在上涨空间。其他分析师也调整了他们的目标，巴克莱将其设定为 140.00 美元，瑞银则设定为 155.00 美元。Paychex 的股票交易价格为 150.87 美元，市值为 543.2 亿美元，市盈率为 31.77。该公司报告每股收益为 1.49 美元，超出预期，且股本回报率高达 45.28%</p>

<p>Paychex (NASDAQ:PAYX - Get Free Report) had its price objective increased by stock analysts at Citigroup from $145.00 to $158.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a &#34;neutral&#34; rating on the business services provider's stock. Citigroup's price objective would suggest a potential upside of 4.73% from the stock's previous close.</p>
<div class="lb-trans"><p>药明康德 (NASDAQ:PAYX - 获取免费报告) 在周四向投资者发布的研究报告中，花旗集团的股票分析师将其目标价格从 145.00 美元上调至 158.00 美元，Benzinga 报道。该公司目前对这家商业服务提供商的股票给予 “中性” 评级。花旗集团的目标价格暗示该股票相较于之前的收盘价有 4.73% 的潜在上涨空间。</p>
</div><ul>
<li>Why Paychex Stock's Dip is the Best Opportunity in Today's Cycle</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么药明康德股票的下跌是当前周期中最佳机会</li>
</ul>
</div><p>A number of other equities analysts also recently commented on PAYX. Barclays upped their price objective on shares of Paychex from $135.00 to $140.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Monday, December 23rd. UBS Group increased their price target on shares of Paychex from $152.00 to $155.00 and gave the stock a &#34;neutral&#34; rating in a report on Tuesday, March 4th. Stifel Nicolaus lifted their price objective on Paychex from $141.00 to $156.00 and gave the company a &#34;hold&#34; rating in a report on Thursday. Finally, Royal Bank of Canada reissued a &#34;sector perform&#34; rating and set a $148.00 target price on shares of Paychex in a research note on Friday, December 20th. Two analysts have rated the stock with a sell rating and ten have assigned a hold rating to the stock. Based on data from MarketBeat, Paychex has an average rating of &#34;Hold&#34; and a consensus target price of $136.83.</p>
<div class="lb-trans"><p>其他一些股票分析师最近也对 PAYX 发表了评论。巴克莱将药明康德的目标价格从 135.00 美元上调至 140.00 美元，并在 12 月 23 日的研究报告中给予该股票 “等权重” 评级。瑞银集团将药明康德的目标价格从 152.00 美元上调至 155.00 美元，并在 3 月 4 日的报告中给予该股票 “中性” 评级。斯蒂费尔·尼古拉斯将药明康德的目标价格从 141.00 美元上调至 156.00 美元，并在周四的报告中给予该公司 “持有” 评级。最后，加拿大皇家银行在 12 月 20 日的研究报告中重新发布了 “行业表现” 评级，并设定了 148.00 美元的目标价格。两位分析师对该股票给予了卖出评级，十位分析师则给予了持有评级。根据 MarketBeat 的数据，药明康德的平均评级为 “持有”，共识目标价格为 136.83 美元。</p>
</div><p><strong>Read Our Latest Analysis on Paychex</strong></p>
<div class="lb-trans"><p><strong>阅读我们对药明康德的最新分析</strong></p>
</div><h2>Paychex Stock Performance</h2>
<div class="lb-trans"><h2>药明康德股票表现</h2>
</div><ul>
<li>Buy the Dip in Paychex, Inc. for a Pay Check at Retirement</li>
</ul>
<div class="lb-trans"><ul>
<li>在药明康德公司买入下跌的股票，以便在退休时获得薪水</li>
</ul>
</div><p>Shares of PAYX traded up $0.68 during mid-day trading on Thursday, hitting $150.87. 1,049,015 shares of the company's stock were exchanged, compared to its average volume of 1,796,058. The company has a current ratio of 1.39, a quick ratio of 1.39 and a debt-to-equity ratio of 0.20. Paychex has a fifty-two week low of $114.72 and a fifty-two week high of $158.37. The business's 50 day moving average is $148.03 and its two-hundred day moving average is $143.04. The firm has a market capitalization of $54.32 billion, a P/E ratio of 31.77, a P/E/G ratio of 4.10 and a beta of 0.98.</p>
<div class="lb-trans"><p>周四中午交易时，药明康德的股票上涨 0.68 美元，达到 150.87 美元。该公司的股票交易量为 1,049,015 股，而其平均交易量为 1,796,058 股。该公司的流动比率为 1.39，速动比率为 1.39，债务与股本比率为 0.20。药明康德的 52 周低点为 114.72 美元，52 周高点为 158.37 美元。该公司的 50 日移动平均线为 148.03 美元，200 日移动平均线为 143.04 美元。该公司的市值为 543.2 亿美元，市盈率为 31.77，市盈率/增长比率为 4.10，贝塔值为 0.98。</p>
</div><p>Paychex (NASDAQ:PAYX - Get Free Report) last posted its quarterly earnings data on Wednesday, March 26th. The business services provider reported $1.49 earnings per share for the quarter, topping analysts' consensus estimates of $1.48 by $0.01. The company had revenue of $1.51 billion during the quarter, compared to analysts' expectations of $1.51 billion. Paychex had a return on equity of 45.28% and a net margin of 32.02%. The firm's revenue for the quarter was up 4.8% on a year-over-year basis. During the same period last year, the firm earned $1.38 EPS. On average, equities analysts expect that Paychex will post 4.99 earnings per share for the current year.</p>
<div class="lb-trans"><p>药明康德 (NASDAQ:PAYX - 获取免费报告) 最近在 3 月 26 日发布了季度财报。该商业服务提供商报告本季度每股收益为 1.49 美元，超出分析师一致预期的 1.48 美元 0.01 美元。该公司本季度的收入为 15.1 亿美元，而分析师预期的收入为 15.1 亿美元。药明康德的股本回报率为 45.28%，净利润率为 32.02%。该公司的季度收入同比增长 4.8%。去年同期，该公司每股收益为 1.38 美元。分析师平均预计药明康德在当前年度的每股收益为 4.99 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><ul>
<li>3 payroll companies get clocked, but 1 looks cheap</li>
</ul>
<div class="lb-trans"><ul>
<li>三家薪资公司遭遇重创，但一家看起来便宜</li>
</ul>
</div><p>Several institutional investors have recently modified their holdings of PAYX. Meeder Asset Management Inc. boosted its stake in shares of Paychex by 220.7% during the fourth quarter. Meeder Asset Management Inc. now owns 186 shares of the business services provider's stock valued at $26,000 after acquiring an additional 128 shares during the last quarter. Union Bancaire Privee UBP SA purchased a new position in Paychex in the 4th quarter valued at about $28,000. WealthTrak Capital Management LLC acquired a new stake in shares of Paychex during the 4th quarter worth about $28,000. Millstone Evans Group LLC purchased a new stake in shares of Paychex during the fourth quarter worth about $33,000. Finally, Avion Wealth grew its holdings in shares of Paychex by 469.8% during the fourth quarter. Avion Wealth now owns 245 shares of the business services provider's stock worth $34,000 after buying an additional 202 shares in the last quarter. 83.47% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>几家机构投资者最近调整了对 PAYX 的持股。Meeder 资产管理公司在第四季度将其在药明康德的股份增加了 220.7%。Meeder 资产管理公司现在拥有 186 股该商业服务提供商的股票，价值 26,000 美元，此前在上个季度增持了 128 股。联合银行私人银行 UBP SA 在第四季度购买了药明康德的新头寸，价值约 28,000 美元。WealthTrak 资本管理公司在第四季度获得了药明康德的新股份，价值约 28,000 美元。Millstone Evans 集团在第四季度购买了药明康德的新股份，价值约 33,000 美元。最后，Avion Wealth 在第四季度将其在药明康德的持股增加了 469.8%。Avion Wealth 现在拥有 245 股该商业服务提供商的股票，价值 34,000 美元，此前在上个季度增持了 202 股。目前 83.47% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>About Paychex</h2>
<div class="lb-trans"><h2>关于药明康德</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Paychex, Inc, together with its subsidiaries, provides integrated human capital management solutions (HCM) for payroll, benefits, human resources (HR), and insurance services for small to medium-sized businesses in the United States, Europe, and India. It offers payroll processing services; payroll tax administration services; employee payment services; and regulatory compliance services, such as new-hire reporting and garnishment processing.</p>
<div class="lb-trans"><p>药明康德公司及其子公司为美国、欧洲和印度的小型和中型企业提供集成人力资本管理解决方案（HCM），包括薪资、福利、人力资源（HR）和保险服务。它提供薪资处理服务；薪资税务管理服务；员工支付服务；以及合规服务，如新员工报告和扣押处理。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>阅读更多</h2>
</div><ul>
<li>Five stocks we like better than Paychex</li>
<li>What is Short Interest? How to Use It</li>
<li>Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell</li>
<li>Expert Stock Trading Psychology Tips</li>
<li>Top 3 Beverage Stocks Pouring Out Profits</li>
<li>How to Read Stock Charts for Beginners</li>
<li>CarMax and Carvana: Steering the Used Car Market</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过药明康德</li>
<li>什么是空头头寸？如何使用它</li>
<li>便士股票激增 70%：买入的一个理由，卖出的五个理由</li>
<li>专家股票交易心理技巧</li>
<li>三大饮料股票带来丰厚利润</li>
<li>如何为初学者阅读股票图表</li>
<li>CarMax 和 Carvana：引领二手车市场</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UEFZWA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=PAYX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Paychex Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在药明康德吗？</h2>
</div><p>Before you consider Paychex, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑药明康德之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Paychex wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而药明康德并不在名单上。</p>
</div><p>While Paychex currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然药明康德目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

花旗银行将沛齐（纳斯达克股票代码：PAYX）的目标价上调至 158.00 美元